508 related articles for article (PubMed ID: 16762617)
1. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
4. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
5. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
7. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.
Rutter MD; Saunders BP; Wilkinson KH; Rumbles S; Schofield G; Kamm MA; Williams CB; Price AB; Talbot IC; Forbes A
Gut; 2004 Dec; 53(12):1813-6. PubMed ID: 15542520
[TBL] [Abstract][Full Text] [Related]
8. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
9. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis.
Loftus EV
Gastroenterol Clin North Am; 2006 Sep; 35(3):517-31. PubMed ID: 16952738
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
13. [Frequency and predictive factors of colectomy and restorative colo-proctectomy in ulcerative colitis].
Karoui S; Serghini M; Chaieb M; Jomni T; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
Tunis Med; 2009 Feb; 87(2):115-9. PubMed ID: 19522443
[TBL] [Abstract][Full Text] [Related]
14. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.
Rutter MD; Saunders BP; Wilkinson KH; Rumbles S; Schofield G; Kamm MA; Williams CB; Price AB; Talbot IC; Forbes A
Gastroenterology; 2006 Apr; 130(4):1030-8. PubMed ID: 16618396
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
16. Risk of colorectal cancer in ulcerative colitis in India.
Venkataraman S; Mohan V; Ramakrishna BS; Peter S; Chacko A; Chandy G; Kurian G; Kurian S; Mathan M; Mathan VI; Patra S; Pulimood A; Rolston DD
J Gastroenterol Hepatol; 2005 May; 20(5):705-9. PubMed ID: 15853982
[TBL] [Abstract][Full Text] [Related]
17. Ulcerative colitis and colorectal cancer. A population-based study.
Ekbom A; Helmick C; Zack M; Adami HO
N Engl J Med; 1990 Nov; 323(18):1228-33. PubMed ID: 2215606
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
19. Statin use and risk of colorectal cancer.
Coogan PF; Smith J; Rosenberg L
J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
[TBL] [Abstract][Full Text] [Related]
20. Cancer surveillance in ulcerative colitis.
Chambers WM; Warren BF; Jewell DP; Mortensen NJ
Br J Surg; 2005 Aug; 92(8):928-36. PubMed ID: 16034807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]